The Department of Health and Social Care has announced almost £30 million in funding to roll out AI-powered diagnostic technology to every NHS Trust in England by 2029, alongside a separate pilot programme for six new AI and digital tools.
The announcement, published on 10 June 2026 by DHSC jointly with the Department for Science, Innovation and Technology and NHS England, centres on two strands of funding under the government's AI Diagnostic Fund, part of the Prime Minister's AI Exemplars programme.
The larger tranche of £20 million will extend AI-powered chest X-ray analysis tools, already in use across roughly half of England's NHS Trusts, to every Trust by 2029. The technology operates as a "second pair of eyes" for radiologists, flagging findings on chest X-rays for clinician review.
According to the government, the tools have already supported faster lung cancer diagnosis or all-clear results for more than four million patients, with early data showing average scan analysis times falling from eight days to four days for complex cases. Chest X-rays are used in over seven million NHS examinations annually and form a key part of lung cancer pathways under the National Cancer Plan's 62-day treatment standard.
A second, smaller fund of £8.1 million from the National Institute for Health and Care Research (NIHR) will support pilots of six AI and digital technologies across 12 NHS Trusts and one GP partnership in England and Scotland. These will cover analysis of CT scans, ECGs and X-rays, digital therapy delivery, and triage tools for prioritising urgent cases, targeting conditions including heart failure, stroke, lung cancer, lung infections and tic disorders. Technologies that demonstrate effectiveness through these pilots are expected to follow the same wider rollout pathway as the chest X-ray tools.
Eextending AI diagnostic tools to every NHS Trust in England has clear implications for information governance functions within those trusts.
Each AI diagnostic deployment will typically require a Data Protection Impact Assessment (DPIA) under Article 35 UK GDPR, given the processing of special category health data through automated or AI-assisted analysis. Trusts will also need to consider the extent to which any AI-supported diagnostic output constitutes a decision "based solely on automated processing" for the purposes of Article 22 UK GDPR, although the government and NHS leaders have repeatedly stressed that clinicians remain in control of diagnostic decisions, with the tools designed to support rather than replace radiologist judgement.
The Royal College of Radiologists, while welcoming the investment, emphasised that evidence-based, clinician-led implementation will be key to the success of these tools as they are rolled out more widely, with radiologists remaining central to diagnosis and clinical decision-making.
